Medidata TSDV

More than 50% of site monitoring budgets are spent on source data verification (SDV). Yet verifying every data field rarely changes outcomes.

Medidata TSDV (Targeted Source Data Verification) focuses verification on critical safety and efficacy data in Rave EDC, helping you reduce unnecessary effort without compromising regulatory confidence.

Download Overview
 

SDV Built around Risk

TSDV turns SDV into a structured, risk-aligned strategy. You define what requires verification, at what level, and where, aligned to study-level risk assessments.

Built inside Rave EDC, it enables study- and site-specific SDV strategies while maintaining full coverage of critical safety and efficacy data.

Critical Data Focus
Inspection
Readiness
Study- and Site- Specific SDV
Field-level Verification

Reduced SDV Strategy in Practice

Lower Monitoring Cost

Control SDV-driven
Monitoring Costs

Move away from 100% SDV and apply verification only where risk strategy requires it. By reducing unnecessary verification activity and site visits, you lower monitoring costs without compromising oversight.

Download Fact Sheet

Featured Resource


From 50% to Targeted 15–20% SDV

Nordic Bioscience replaced manual SDV tracking with Medidata TSDV and piloted true risk-based monitoring. The result: streamlined execution and a path toward 15–20% SDV with significant cost savings potential.

Read Case Study

More Resources


Explore deeper guidance and related materials.

View All Resources

FAQ

Medidata TSDV allows study teams to focus Source Data Verification (SDV) efforts on critical-to-quality data rather than 100% of the data. Since SDV often consumes over 50% of site monitoring budgets, this targeted approach significantly reduces the time CRAs spend on low-value data verification, lowering overall monitoring costs without compromising data quality.

Yes. Medidata TSDV offers the flexibility to configure study-specific and site-specific SDV plans. You can define verification requirements down to the specific data field, form, and patient visit level, allowing for a tailored strategy that fits the risk profile of each site.

Yes. The solution is designed to support ICH GCP E6 (R2), E8 (R1), and (R3) compliance. It enables teams to apply a risk-based approach to clinical operations while automatically maintaining a complete, inspection-ready audit trail of exactly what was verified and what was not.

Medidata TSDV is fully unified with Rave EDC and the broader Medidata Platform. This means CRAs are directed to the specific fields requiring verification directly within their workflow, and study managers have full visibility into SDV progress and assignments throughout the trial lifecycle.

Yes. Medidata offers a variety of training options for our clients and partners, including both self-paced and instructor-led courses. To learn more about available courses and to access our resources, please visit the Medidata Global Education and Training section.